Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE The high variation in envelope protein sequence among HCV isolates necessitates the inclusion of several isolates, spanning the major genotypes of HCV, in order to make strong conclusions concerning the cross-reactive neutralization potential of a given antibody. 30593643 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Overall, statistically significant associations were found between HCV quasispecies diversity, selective pressure exerted on the HCV E2 envelope protein, and neutralizing activity of maternal immunoglobulins. 30365007 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE NS2 also promotes HCV particle assembly by recruiting envelope protein 2 (E2) to the virus assembly sites located at the detergent-resistant membranes (DRM). 31597774 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Herein, we evaluated two different semi-synthetic archaeosome formulations as an adjuvant to the E1/E2 HCV envelope protein in a murine model and compared antigen-specific humoral (levels of anti-E1/E2 IgG and HCV pseudoparticle neutralization) and cellular responses (numbers of antigen-specific cytokine-producing T cells) to those generated with adjuvant formulations composed of mimetics of commercial adjuvants including a squalene oil-in-water emulsion, aluminum hydroxide/monophosphoryl lipid A (MPLA) and liposome/MPLA/QS-21. 31816920 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE This is a sensitive and robust method for future studies investigating B cell responses against the HCV Envelope protein. 31226262 2019
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Peterson, F. Gavilanes, Structural properties of the ectodomain of hepatitis C virus E2 envelope protein, Virus Res.139 (2009) 91-99). 29273334 2018
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE The molecular basis for the inhibitory action of a benzimidazole inhibitor compound to hepatitis C virus E1 envelope protein was examined computationally. 29745064 2018
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE In summary, mAb A6 is an important tool to study the structure and function of E1 within the viral envelope, a crucial step in the development of an effective prophylactic HCV vaccine. 29128754 2018
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Interestingly, the inhibition of autophagy by ATG7 knockdown reduced the colocalization of ApoE with the HCV E2 envelope protein and the HCV titers released from cells. 29695434 2018
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE The dynamic properties of the Hepatitis C Virus E2 envelope protein unraveled by molecular dynamics. 26973093 2017
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE The initial induction of TNF-α by HCV was prompt and could be blocked by the antibody directed against the HCV E2 envelope protein and by chemicals that inhibit endocytosis, indicating the specificity of endocytic uptake of HCV in this induction. 26023919 2015
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine. 26742442 2015
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Here we review current knowledge of HCV envelope protein structure, integrating knowledge of genetic, antigenic and functional diversity to inform rational immunogen design. 26193307 2015
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Hypervariable region 1 (HVR1) of envelope protein 2 (E2) of hepatitis C virus (HCV) serves important yet undefined roles in the viral life cycle. 24257605 2014
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Sixty-two (43M:19F) patients, from all the patient cohorts, were sequenced and compared for the C section alone (which encompasses the important binding region of the molecule for envelope protein) including 21 (14M:7F) HCV RNA negative, 15 (10M:5F) HCV RNA positive and 26 (20M:6F) exposed uninfected and no sequence differences were observed. 24122777 2014
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Testing replicons expressing representative envelope protein genes from all major HCV genotypes, we observed that virus production occurred in a genotype- and isolate-dependent fashion. 24771613 2014
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. 24991010 2014
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Natural selection of adaptive mutations in non-structural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes. 23288424 2013
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE Two monoclonal antibodies (E8G9 and H1H10) specific for the E2 region of envelope protein of HCV genotype 3a, were found to reduce the virus binding to Huh7 cells. 23341957 2013
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE The activation of AKT could also be mediated by UV-inactivated HCV, HCV pseudoparticle, and the ectodomain of the HCV E2 envelope protein. 23095753 2012
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE To determine whether this holds true for the distantly related hepatitis C virus (HCV), whose neutralizing epitopes may be obscured by a glycan shield, apolipoprotein interactions, and the hypervariable region on the E2 envelope protein, we assessed how time and temperature of pre-incubation altered monoclonal antibody (MAb) neutralization of HCV. 22078164 2012
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE Oral immunization of BALB/c mice with the attenuated Salmonella strain SL7207 carrying this plasmid efficiently induced HCV core and E2-specific cellular immune responses and antibodies. 21396407 2011
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE The effects of inhibitors of N-linked glycosylation on HCV production were evaluated using this cell line, and the results suggest that certain step(s), such as virion assembly, intracellular trafficking, and secretion, are potentially up- and downregulated according to modifications of HCV envelope protein glycans. 20237083 2010
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 GeneticVariation disease BEFREE By development of JFH1-based intergenotypic recombinants containing Core, envelope protein 1 and 2 (E1, E2), p7, and nonstructural protein 2 (NS2) of genotype 6a and 7a strains, as well as subtype 1b and 2b strains, we have completed a panel of culture systems for all major HCV genotypes. 19148942 2009
Entrez Id: 110006328
Gene Symbol: ERVK-32
ERVK-32
0.100 Biomarker disease BEFREE RNA encoding the first 126 amino acids of the HCV E1 envelope protein and the majority of the E1 signal sequence was analyzed in parallel with an 80-base-long segment of the 5' untranslated region (UTR). 18300072 2008